Grasp implementation, grasp implementation, set an example
Release time:
2020-08-14
Grasp Implementation, Grasp Implementation, Lead by Example
Pharmaceutical Company 2016 Outstanding Management Worker Pharmaceutical Company Jinxi Pharmaceutical Factory Wang Fen
I came to Jianfeng Pharmaceutical Company in 2013 6 , starting with verification QA , 2015 7 transferred to the powder needle workshop, successively serving as deputy director of the workshop and director of the workshop. During his tenure as verification QA , he was mainly responsible for the relevant verification work of Jinxi Factory, and successively participated in the verification work of each production line in powder injection workshop, solid preparation workshop and bulk drug workshop, making his own efforts for the new version GMP certification of each line. During his tenure as the workshop director, he grasped the implementation, set an example and led the workshop team to complete various tasks.
I always strictly demand myself according to the standards of party members, complete my own work with a down-to-earth, serious and responsible attitude, and drive and influence the people around me while doing my best.
strict requirements, strengthen the management of all aspects of production. Set an example to play a core role, stress principles, tree rules, to ensure that all production activities in the workshop in accordance with the provisions of the production management documents. After a year of strict attention, the problems of fixed position management, status identification, material location card and account and consistency of physical objects in the workshop site have been significantly improved, and standardized and standardized operations have been realized. Good order and working environment have greatly improved all aspects of management. In 2016 , the powder needle workshop achieved a double harvest of output and quality, as well as "zero accidents" of safe production and environmental protection ".
Strengthen team building and optimize team management. There are three production lines in the powder injection workshop, two of which are in production. In 2016 , the powder needle workshop changed from more than 70 to the current 55 . Under the condition of post optimization and personnel reduction, the workshop made reasonable allocation of personnel in various posts and provided relevant training to the transferred personnel so that they could take up their posts in a relatively short period of time. In particular, for the aseptic operators in the B area (sub-packaging and filling), the focus is on business training, and all of them are experts in operation and backbone of business. Various measures have strengthened the team's joint efforts and created a good atmosphere of mutual assistance, complementarity, mutual progress and mutual promotion.
Efforts to study business, the courage to learn hard bones, the courage to "bright sword" to technical problems ". 2016 , according to the freeze-drying line production plan, we found the relationship between the amount of liquid preparation and the number of layers filled in the freeze-drying box, and determined the most suitable batch size of each product, so that the finished product rate of each product was increased by 3%-5% compared with 2015 . 2016 2 Since September, the first-line cefmenoxime hydrochloride for cephalosporin injection has been using the raw materials produced by Jinxi Factory one after another. During the production process, there will be phenomena such as mixing powder, difficulty in sub-packing powder and difficulty in controlling the difference in sub-packing quantity. We mobilized the workshop staff to study together and finally solved this problem. 2016 The powder injection workshop produced a total of 98 batches of cephalosporin products and 34 batches of freeze-dried products throughout the year. The qualified rate of the batch reached 100% . At the same time, it successfully completed the simulated sub-packaging and filling work of two lines twice a year, accepted the flight inspection of Zhejiang Provincial Market Supervision and Administration Bureau and Jinhua Municipal Market Supervision and Administration Bureau, and got the approval of the leadership.
Strengthen quality management and improve the comprehensive ability of all employees. Because the education level of the staff in the workshop is different, the quality of the staff is also uneven, which requires training and guidance. I attach great importance to the concept and ideological education, strengthen the positive energy, establish a good fashion. I often communicate with employees, and use the good people and good things around me to guide; targeted and timely training, guidance, different people take different ways. Improving the skill level of personnel is a cumulative process, and it is very important to persevere. In 2016 , the powder injection workshop organized its employees to carry out training on process regulations, production utilities SOP , post SOP , drug production quality management regulations, production management regulations, material management regulations, quality and document management regulations, drug production laws and regulations, etc. The use of training as a platform has effectively promoted the improvement of the overall quality of employees. (According to Wang Fen's speech at the summary and commendation meeting of the pharmaceutical company)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page